Methanol → N-({(5S)-3-[4-(3-azabicyclo[3.1.0]hex-3-yl)-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl) acetamide

HRID 1814032

反応式

HRID 1814032 の反応式
[O-]CCCC.[Li+].[CH2:7]([O:14][C:15](=[O:30])[NH:16][C:17]1[CH:22]=[CH:21][C:20]([N:23]2[CH2:28][CH:27]3[CH:25]([CH2:26]3)[CH2:24]2)=[C:19]([F:29])[CH:18]=1)[C:8]1C=CC=CC=1.CO.[C:33]([NH:36][CH2:37][C@H](OC(=O)C)CCl)(=[O:35])[CH3:34].[Cl-].[NH4+]>CN(C=O)C.[Cl-].[Na+].O.O.C1COCC1>[CH:27]12[CH2:26][CH:25]1[CH2:24][N:23]([C:20]1[CH:21]=[CH:22][C:17]([N:16]3[CH2:8][C@H:7]([CH2:37][NH:36][C:33](=[O:35])[CH3:34])[O:14][C:15]3=[O:30])=[CH:18][C:19]=1[F:29])[CH2:28]2

参加物

10

実験手順

Lithium butoxide solution (2.5 mL of a 1.0 M THF solution, 2.5 mmol) was added to a cooled (0° C.) solution of [4-(3-aza-bicyclo[3.1.0]hex-3-yl)-3-fluoro-phenyl]-carbamic acid benzyl ester (0.267 g, 0.82 mmol) in DMF (0.6 mL) and MeOH (0.060 mL, 1.64 mmol). Solid (S)-acetic acid 2-acetylamino-1-chloromethyl-ethyl ester (0.316 g, 1.64 mmol) was then added and the solution allowed to warm to room temperature and stirred for 20 h. Saturated aqueous ammonium chloride (1.0 mL) was added, along with 9 mL of H2O and 8 mL of brine. The solution was extracted with three portions of dichloromethane and the combined organic phases dried (MgSO4), filtered and concentrated. The crude product was purified by column chromatography (0-3% MeOH-DCM) to provide N-({(5S)-3-[4-(3-azabicyclo[3.1.0]hex-3-yl)-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl) acetamide.

後処理

  1. extractionThe solution was extracted with three portions of dichloromethane
  2. dry with materialthe combined organic phases dried (MgSO4)
  3. filtrationfiltered
  4. concentrationconcentrated
  5. customThe crude product was purified by column chromatography (0-3% MeOH-DCM)

出典と根拠

ORDレコード
ord-6bfc18fc535341e88e7b899c30916ae8
出典データセット
uspto-grants-2005_04
特許番号
US06875784B2

関連ノート

読み込み中…